APA (7th ed.) Citation

DeZure, A. D., Coates, E. E., Hu, Z., Yamshchikov, G. V., Zephir, K. L., Enama, M. E., . . . Ledgerwood, J. E. (2017, June). An avian influenza H7 DNA priming vaccine is safe and immunogenic in a randomized phase I clinical trial. npj Vaccines.

Chicago Style (17th ed.) Citation

DeZure, Adam D., et al. "An Avian Influenza H7 DNA Priming Vaccine Is Safe and Immunogenic in a Randomized Phase I Clinical Trial." Npj Vaccines Jun. 2017.

MLA (9th ed.) Citation

DeZure, Adam D., et al. "An Avian Influenza H7 DNA Priming Vaccine Is Safe and Immunogenic in a Randomized Phase I Clinical Trial." Npj Vaccines, Jun. 2017.